UNSPSC 51381902: Fenpipalone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H22N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6TVC31DEDE, chemically known as 5-(2-(3,6-dihydro-4-phenyl-1(2h)-pyridyl)ethyl)-3-methyl-2-oxazolidinone but generally known as fenpipalone, which bears US NIH Compound Identifier 30822. European Medicines Agency schedules Fenpipalone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07587MIG.

UNSPSC 51381902 Fenpipalone, a Commodity code, encompasses pharmaceutical and medical products that state and local health agencies acquire for community health and emergency response programs. The recent solicitation activity under this code shows state and local governments buying naloxone and drug deactivation systems to support opioid-response and community health initiatives, though the code's nominal scope (fenpipalone, a specific pharmaceutical compound) does not align closely with the naloxone and harm-reduction equipment actually being procured. Health departments and county health agencies are the primary issuing bodies, sourcing these products through competitive bidding to meet public health demand.

Seminole County, Florida posted an IFB (Invitation for Bid) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. The procurement required vendors to submit bids electronically, include all shipping and delivery costs, maintain workers' compensation and professional liability insurance, comply with drug-free workplace and E-Verify requirements, and accept a two-year initial term with one-year renewal option. Activity under this code appears limited to this single recent opportunity; broader geographic and issuing-body patterns are not supported by the available data.